🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/05/1987 | 7,95 | 7,95 | 7,81 | 7,90 | -0,67% | 1,75% | 8.073.792 |
| 15/05/1987 | 8,04 | 8,07 | 7,95 | 7,95 | -1,80% | 1,57% | 11.463.653 |
| 14/05/1987 | 8,14 | 8,16 | 8,06 | 8,10 | -0,16% | 1,22% | 4.551.883 |
| 13/05/1987 | 8,16 | 8,18 | 8,06 | 8,11 | -0,41% | 1,46% | 5.583.744 |
| 12/05/1987 | 8,04 | 8,14 | 7,95 | 8,14 | +1,40% | 2,39% | 6.568.445 |
| 11/05/1987 | 8,15 | 8,30 | 8,00 | 8,03 | -0,98% | 3,66% | 7.809.696 |
| 08/05/1987 | 8,16 | 8,16 | 8,04 | 8,11 | -0,24% | 1,54% | 5.883.682 |
| 07/05/1987 | 8,10 | 8,16 | 8,08 | 8,13 | +0,41% | 0,98% | 7.085.318 |
| 06/05/1987 | 8,26 | 8,32 | 8,06 | 8,10 | -2,16% | 3,05% | 9.390.499 |
| 05/05/1987 | 8,00 | 8,31 | 8,00 | 8,28 | +4,43% | 3,81% | 12.646.426 |
| 04/05/1987 | 7,81 | 7,93 | 7,80 | 7,93 | +1,36% | 1,61% | 6.962.702 |
| 01/05/1987 | 7,82 | 7,91 | 7,80 | 7,82 | +0,00% | 1,44% | 10.380.859 |
| 30/04/1987 | 7,75 | 7,87 | 7,74 | 7,82 | +1,11% | 1,71% | 9.443.318 |
| 29/04/1987 | 7,85 | 7,87 | 7,71 | 7,73 | -0,85% | 2,03% | 8.686.872 |
| 28/04/1987 | 7,81 | 7,88 | 7,77 | 7,80 | +0,25% | 1,44% | 12.761.496 |
| 27/04/1987 | 7,77 | 7,95 | 7,69 | 7,78 | -1,09% | 3,41% | 16.877.621 |
| 24/04/1987 | 8,02 | 8,02 | 7,81 | 7,87 | -2,54% | 2,56% | 14.563.008 |
| 23/04/1987 | 8,11 | 8,15 | 8,01 | 8,07 | +0,16% | 1,72% | 10.884.528 |
| 22/04/1987 | 8,22 | 8,30 | 8,06 | 8,06 | -2,09% | 2,90% | 12.003.163 |
| 21/04/1987 | 8,03 | 8,23 | 7,99 | 8,23 | +1,97% | 2,97% | 13.019.933 |
| 20/04/1987 | 8,16 | 8,19 | 8,02 | 8,07 | -0,81% | 2,11% | 9.243.360 |
| 16/04/1987 | 8,31 | 8,32 | 8,12 | 8,14 | -1,60% | 2,47% | 18.430.128 |
| 15/04/1987 | 8,47 | 8,48 | 8,14 | 8,27 | -1,50% | 3,99% | 15.115.723 |
| 14/04/1987 | 8,46 | 8,47 | 8,24 | 8,40 | -1,02% | 2,66% | 14.730.898 |
| 13/04/1987 | 8,60 | 8,65 | 8,46 | 8,48 | -1,69% | 2,23% | 10.263.902 |
| 10/04/1987 | 8,48 | 8,64 | 8,47 | 8,63 | +0,77% | 2,03% | 13.168.958 |
| 09/04/1987 | 8,65 | 8,68 | 8,49 | 8,56 | -0,92% | 2,22% | 10.724.184 |
| 08/04/1987 | 8,56 | 8,67 | 8,51 | 8,64 | +1,87% | 1,78% | 11.116.555 |
| 07/04/1987 | 8,73 | 8,79 | 8,48 | 8,48 | -3,40% | 3,49% | 11.461.766 |
| 06/04/1987 | 8,70 | 8,79 | 8,65 | 8,78 | +2,24% | 1,52% | 10.486.498 |